NeuroOne Medical Technologies Corporation
NMTC | NASDAQ
$1.38
+$0.08 (+6.15%)
At close: Sep 22, 2026, 4:00 PM ET
$1.39
+$0.01 (+0.72%)
After-hours:
Sep 22, 2026, 7:43 PM ET
Market Data
Market Cap $11.31M
Enterprise Value $9.34M
Beta 0.64
Average Volume 46.22K
Shares Outstanding (Diluted) 8.74M
Shares Change YoY 7.88%
Institutional Ownership 23.26%
Exchange NASDAQ
ISIN US64130M3088
Price Performance
Price Change 1M -36.0%
Price Change 3M -61.2%
Price Change 6M -71.9%
Price Change YTD -74.6%
Price Change 1Y -76.7%
Price Change 3Y -77.2%
Price Change 5Y -94.8%
1M CAGR (ann.) -20.3%
1Y CAGR (ann.) -75.9%
5Y CAGR (ann.) -46.0%
All-Time CAGR -37.6%
Valuation
PE Ratio -1.35
Forward PE N/A
PEG Ratio 0.01
Forward PEG 0.10
PS Ratio 1.13
Forward PS 0.80
PB Ratio 3.00
P/FCF Ratio -1.58
P/Adj. FCF Ratio -1.32
P/OCF Ratio -1.60
EV/Sales 0.93
EV/EBIT -1.17
EV/EBITDA -1.20
EV/FCF -1.30
Earnings Yield -73.8%
FCF Yield -63.3%
Adj. FCF Yield -75.8%
Financial Health
Net Cash $2.05M
Total Debt $73.32K
Cash & Short-Term Investments $2.05M
Total Assets $6.19M
Current Ratio 2.84
Quick Ratio 1.71
Debt / Equity Ratio 0.02
Debt / EBITDA -0.01
Debt / FCF -0.01
OCF / Debt -96.18
Interest Coverage 22.76
Altman Z-Score -18.22
Piotroski F-Score 2
Margins & Profitability
Gross Profit Margin 55.7%
Operating Profit Margin -76.0%
EBITDA Margin -69.1%
Net Profit Margin -71.5%
FCF Margin -71.6%
Adj. FCF Margin -85.8%
SBC / Revenue 14.1%
SBC Impact (per share) -19.7%
Returns
Return on Assets -115.6%
Return on Equity -126.5%
Return on Invested Capital -183.4%
Return on Capital Employed -183.4%
Return on Tangible Assets -116.1%
Historical Growth (CAGR)
Revenue CAGR 3Y 98.4%
Revenue CAGR 5Y 37.2%
Revenue CAGR 10Y 173.2%
EPS CAGR 3Y 138.5%
EPS CAGR 5Y 61.3%
EPS CAGR 10Y 23.4%
FCF CAGR 3Y 28.0%
FCF CAGR 5Y 14.7%
FCF CAGR 10Y -11.0%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 4
EPS Growth Next 3Y 46.5%
Revenue Growth Next 3Y 42.1%
Earnings Date Dec 14, 2026
EPS Estimate (next Q) -$0.22
EPS Growth Est (next Q) -27.8%
Revenue Est (next Q) $2.79M
Revenue Growth Est (next Q) 2.8%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $5
Price Target Upside 284.6%
Cash Flow
Operating Cash Flow $-7.05M
Free Cash Flow $-7.16M
Adj. Free Cash Flow $-8.57M
FCF Per Share -$0.83
OCF Per Share -$0.81
OCF/S Ratio -70.5%
Income Statement
Revenue $10M
Gross Profit $5.57M
Operating Income $-7.6M
EBITDA $-7.8M
Net Income $-7.15M
EPS (Diluted) -$0.96
Revenue / Employee $555.44K
Profit / Employee $-397.17K
Employees 18
Add to Watchlist
Select watchlists to add or remove NMTC